Tutorials
ASX:BOT (Australia)  
Botanix Pharmaceuticals Ltd logo

Botanix Pharmaceuticals Ltd

A$ 0.08 (-2.41%) Aug 5
P/E:
At Loss
P/B:
5.40
Market Cap:
A$ 79.32M ($ 54.81M)
Enterprise V:
A$ 62.67M ($ 43.30M)
Volume:
544.83K
Avg Vol (2M):
816.50K
Also Trade In:
Volume:
544.83K
Market Cap A$:
79.32M
Market Cap $:
54.81M
PE Ratio:
At Loss
Avg Vol (2-Month):
816.50K
Enterprise Value A$:
62.67M
Enterprise Value $:
43.30M
PB Ratio:
5.40
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website Sources Stock Report
Dataset
Financial Download Tutorials

Business Description

Botanix Pharmaceuticals Ltd
NAICS : 325414 SIC : 2836
50 Angove Street, Level 1, Perth, WA, AUS, 6006
Description
Botanix Pharmaceuticals Ltd is a clinical stage cannabinoid therapeutics company. The company focus is the development of safe and effective topical treatments for serious skin conditions. It has an exclusive license to use a proprietary drug delivery system - Permetrex for direct skin delivery of active pharmaceuticals in all skin diseases. The company's product pipeline includes BTX1503 - Moderate to Severe Acne, BTX1308 - Plaque Psoriasis, BTX1204 - Atopic Dermatitis, and BTX 1701 - Mild Acne.

Financial Strength

Name Current Vs Industry Vs History
Cash-To-Debt 85.95
Equity-to-Asset 0.83
Debt-to-Equity 0.01
Debt-to-EBITDA -0.02
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0
Distress
Grey
Safe
Beneish M-Score 0
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 59.16
9-Day RSI 63.73
14-Day RSI 63.05
6-1 Month Momentum % -4.92
12-1 Month Momentum % -22.67

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 5.92
Quick Ratio 5.92
Cash Ratio 5.86

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -8.7

Profitability Rank

Name Current Vs Industry Vs History
ROE % -52.49
ROA % -47.77
ROIC % -446.09
ROC (Joel Greenblatt) % -490.64
ROCE % -51.98

Financials

ASX:BOT's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil A$) 0
EPS (TTM) (A$) -0.011
Beta 3.13
Volatility % 75.4
14-Day RSI 63.05
14-Day ATR (A$) 0.003288
20-Day SMA (A$) 0.07565
12-1 Month Momentum % -22.67
52-Week Range (A$) 0.053 - 0.095
Shares Outstanding (Mil) 979.23

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Botanix Pharmaceuticals Ltd Filings

Document Form Filing Date
No Filing Data